Elizabeth J. Brisbois, Ph.D.

Associate Professor

Designs materials for medical devices using human body molecules

Therapeutic delivery and medical device materials are needed to prevent severe complications such as thrombosis, inflammation, and infection for cardiovascular, pulmonary, diabetes, and dental related patient care. Brisbois is intent on finding a better way. Her research focuses on the design and development of novel therapeutics and medical device materials using molecules that exist in our bodies to enhance compatibility and reduce complication.

Education
  • Ph.D., Chemistry, University of Michigan, 2014
  • M.S., Chemistry, University of Michigan, 2010
  • B.S., Chemistry, Concordia University, Seward, NE, 2008
  • B.S.Ed., Secondary Education, Concordia University, Seward, NE, 2008
Professional Appointments
  • Assistant Professor, University of Georgia College of Engineering, School of Chemical, Materials & Biomedical Engineering, 2020 – present
  • Assistant Professor, University of Central Florida, Department of Materials Science & Engineering, 2017-2020
  • NIH Postdoctoral Fellow, Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI, 2014-2017
Awards & Honors
  • JDRF / FDA Workshop Invited Speaker (1 of 10 invited from U.S.), 2021
  • UCF College of Engineering & Computer Science Dean’s ADI Award, 2019
  • Baxter Young Investigator Award (Baxter, Inc.), 2016
  • National Institute of Health Postdoctoral Fellowship (NRSA F32), 2015
  • MICHR PTSP Career Development Award, 2015
  • University of Michigan – Chemistry Research Excellence Fellowship, 2014
  • Society for Biomaterials STAR Award, 2014
Areas of Expertise
  • Antimicrobial and Hemocompatible Interfaces
  • Anti-inflammatory Biomaterials
  • Clinical Translational Research
  • Insulin Delivery
  • Polymer and Small Molecule Chemistry
  • Pulmonary and Dental Therapeutics
  • Tissue Engineering and Biomaterials
Publications
Patents
  • Nitric oxide-releasing polymer filling for biomedical tubing applications
    European Patent 2 953 660
  • Thromboresistant / bactericidal S-nitroso-N-acetylpenicillamine (SNAP)-doped nitric oxide release polymers with enhanced stability.
    European Patent 2 953 660
  • Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly (lactic-co-glycolic acid) additive.
    U.S. Patent 9,566,372
  • Gas delivery devices
    U.S. Patent 10,449,321
  • Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly (lactic-co-glycolic acid) additive
    U.S. 9,566,372
Other Links

Join a cutting-edge engineering program at a time-honored university

Apply Today Make A Gift